Cargando…
Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis
Colorectal cancer remains the third leading cause of cancer death worldwide, suggesting exploration of novel therapeutic avenues may be useful. In this study, therefore, we determined whether Tianfoshen oral liquid, a Chinese traditional medicine that has been used to treat non-small cell lung cance...
Autores principales: | Wang, Siliang, Wang, Hengbin, Lu, Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362425/ https://www.ncbi.nlm.nih.gov/pubmed/28099904 http://dx.doi.org/10.18632/oncotarget.14675 |
Ejemplares similares
-
Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy
por: Zhao, Lei, et al.
Publicado: (2019) -
Evaluating Drug Risk Using GAN and SMOTE Based on CFDA's Spontaneous Reporting Data
por: Wei, Jianxiang, et al.
Publicado: (2021) -
Colorectal Carcinogenesis: A Cellular Response to Sustained Risk Environment
por: Fung, Kim Y. C., et al.
Publicado: (2013) -
Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population
por: Wang, Peipei, et al.
Publicado: (2020) -
Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products
por: Liu, Yiman, et al.
Publicado: (2020)